Featured Research

from universities, journals, and other organizations

New patenting guidelines needed for biotechnology, experts argue

Date:
April 22, 2014
Source:
Rice University
Summary:
Biotechnology scientists must be aware of the broad patent landscape and push for new patent and licensing guidelines, according to a new paper. Biotechnological inventions have been patented for several decades, though the criteria for patent eligibility have been refined through numerous court decisions. One of the most influential determined that "anything under the sun made by man" could be patented, leading to the diverse biotechnology patent landscape seen today, the authors said.

Biotechnology scientists must be aware of the broad patent landscape and push for new patent and licensing guidelines, according to a new paper from Rice University's Baker Institute for Public Policy.

Published in the current issue of the journal Regenerative Medicine, the paper is based on the June 2013 U.S. Supreme Court ruling in the case Association for Molecular Pathology (AMP) v. Myriad Genetics that naturally occurring genes are unpatentable. The court case and rulings garnered discussion in the public about patenting biological materials.

"The AMP v. Myriad Genetics case raises questions about the patent system," said Kirstin Matthews, the Baker Institute fellow in science and technology policy and an expert on ethical and policy issues related to biomedical research and development. She co-authored the paper with Maude Rowland Cuchiara, the Baker Institute scholar for science and technology policy. The paper has timely significance in light of President Barack Obama's recent announcements on reforming the nation's patent process, including an initiative announced in February to "crowdsource" the review of patents.

"There are not many opportunities to challenge patents once they have been granted, and the options that are available are costly and mostly limited to lawsuits," Matthews said. Judges typically do not have the scientific knowledge to understand some of the technical arguments that are made in their courts, she said. "It may be better, as President Obama has proposed, to revise patenting guidelines at the U.S. Patent and Trademark Office based on feedback from scientists, engineers, ethicists and policy scholars as opposed to leaving it up to the courts."

Until the Supreme Court's decision, Myriad Genetics was the only company in the U.S. that could legally conduct diagnostic testing for BRCA 1 and 2, genes that are linked to familial breast and ovarian cancer. The company was granted the patents in 1998 and 2000, respectively. Myriad chose not to license the patents and harshly pursued anyone who infringed on them.

"The patenting of the BRCA genes launched a raucous debate about the ability to patent life: How do we distinguish between what is simply discovered and what is truly 'made by man'?" the authors asked.

Biotechnological inventions have been patented for several decades, though the criteria for patent eligibility have been refined through numerous court decisions, according to the authors. One of the most influential was Diamond v. Chakrabarty, which determined that "anything under the sun made by man" could be patented, leading to the diverse biotechnology patent landscape seen today, the authors said. However, biotechnological patents must meet the same requirements as all other patents, and they cannot be laws of nature, physical phenomena or abstract ideas.

The authors said the ruling could affect the patentability of other biotechnologies, like stem cells, depending on how the ruling is interpreted. Stem cells, like genes, are also isolated from the body although they do require some manipulation after isolation. But it is likely that if stem cell patents include detailed procedures for the manipulations beyond isolation, they will be upheld. "However these types of patents could also be challenged for failing to meet other patenting requirements like non-obviousness -- meaning that they were not really unique or original after all," the authors said.

Overall, it remains to be seen what impact the ruling in the AMP v. Myriad Genetics case will have on the biotech industry or if any patenting requirements will be changed in response to this or other court rulings, the authors said. So far, the patentability of biotechnological inventions appears to remain unaffected. "However, as more and more biotechnological inventions are patented, the line between what is and is not a 'product of nature' becomes blurred and will most likely continue to be decided in a courtroom," the authors said.

The authors suggest initial steps to address the current situation, including an outside review of patents before they are granted, reforming the rules of patent licensing to minimize restrictive practices and requiring detailed patent descriptions to prevent expensive and disruptive lawsuits.

"Moving forward, scientists must be aware of the broad patent landscape and push for new patent and licensing guidelines," the authors said. "This could keep patents out of court, make the patenting process more seamless and help to spur innovation."


Story Source:

The above story is based on materials provided by Rice University. The original article was written by Jeff Falk. Note: Materials may be edited for content and length.


Journal Reference:

  1. Kirstin RW Matthews, Maude L Cuchiara. Gene patents, patenting life and the impact of court rulings on US stem cell patents and research. Regenerative Medicine, 2014; 9 (2): 191 DOI: 10.2217/rme.13.93

Cite This Page:

Rice University. "New patenting guidelines needed for biotechnology, experts argue." ScienceDaily. ScienceDaily, 22 April 2014. <www.sciencedaily.com/releases/2014/04/140422130942.htm>.
Rice University. (2014, April 22). New patenting guidelines needed for biotechnology, experts argue. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2014/04/140422130942.htm
Rice University. "New patenting guidelines needed for biotechnology, experts argue." ScienceDaily. www.sciencedaily.com/releases/2014/04/140422130942.htm (accessed July 30, 2014).

Share This




More Science & Society News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Climate Change Could Cost Billions, According To White House

Climate Change Could Cost Billions, According To White House

Newsy (July 29, 2014) A report from the White House warns not curbing greenhouse gas emissions could cost the U.S. billions. Video provided by Newsy
Powered by NewsLook.com
Climate Change Could Cost Billions According To White House

Climate Change Could Cost Billions According To White House

Newsy (July 29, 2014) A report from the White House warns not curbing greenhouse gas emissions could cost the U.S. billions. Video provided by Newsy
Powered by NewsLook.com
It's Not Just Facebook: OKCupid Experiments With Users Too

It's Not Just Facebook: OKCupid Experiments With Users Too

Newsy (July 29, 2014) If you've been looking for love online, there's a chance somebody has been looking at how you're looking. Video provided by Newsy
Powered by NewsLook.com
How Your Face Can Leave A Good Or Bad First Impression

How Your Face Can Leave A Good Or Bad First Impression

Newsy (July 29, 2014) Researchers have found certain facial features can make us seem more attractive or trustworthy. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins